BG
Bollard Group’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-153
| Closed | -$5K | – | 507 |
|
|
2023
Q2 | $5K | Buy |
+153
| New | +$5K | ﹤0.01% | 390 |
|
|
2019
Q3 | – | Sell |
-54,759
| Closed | -$2.19M | – | 242 |
|
|
2019
Q2 | $2.19M | Buy |
54,759
+775
| +1% | +$31K | 0.08% | 110 |
|
|
2019
Q1 | $2.26M | Buy |
53,984
+653
| +1% | +$27.3K | 0.09% | 106 |
|
|
2018
Q4 | $2.04M | Buy |
53,331
+159
| +0.3% | +$6.08K | 0.09% | 99 |
|
|
2018
Q3 | $2.14M | Buy |
53,172
+151
| +0.3% | +$6.07K | 0.09% | 103 |
|
|
2018
Q2 | $2.14M | Buy |
53,021
+197
| +0.4% | +$7.94K | 0.1% | 99 |
|
|
2018
Q1 | $2.06M | Buy |
+52,824
| New | +$2.06M | 0.1% | 104 |
|
|
2017
Q4 | – | Sell |
-51,453
| Closed | -$2.09M | – | 259 |
|
|
2017
Q3 | $2.09M | Buy |
51,453
+578
| +1% | +$23.5K | 0.11% | 103 |
|
|
2017
Q2 | $2.19M | Buy |
50,875
+678
| +1% | +$29.2K | 0.12% | 102 |
|
|
2017
Q1 | $2.12M | Buy |
50,197
+581
| +1% | +$24.5K | 0.12% | 101 |
|
|
2016
Q4 | $1.91M | Buy |
49,616
+537
| +1% | +$20.7K | 0.12% | 103 |
|
|
2016
Q3 | $2.12M | Buy |
49,079
+346
| +0.7% | +$14.9K | 0.14% | 92 |
|
|
2016
Q2 | $2.11M | Buy |
48,733
+18,611
| +62% | +$807K | 0.14% | 84 |
|
|
2016
Q1 | $1.22M | Buy |
30,122
+406
| +1% | +$16.5K | 0.1% | 115 |
|
|
2015
Q4 | $1.2M | Buy |
29,716
+428
| +1% | +$17.3K | 0.1% | 115 |
|
|
2015
Q3 | $1.13M | Buy |
29,288
+5,230
| +22% | +$201K | 0.09% | 129 |
|
|
2015
Q2 | $1M | Buy |
24,058
+158
| +0.7% | +$6.58K | 0.08% | 140 |
|
|
2015
Q1 | $1.1M | Buy |
23,900
+13,000
| +119% | +$600K | 0.08% | 129 |
|
|
2014
Q4 | $466K | Buy |
+10,900
| New | +$466K | 0.04% | 158 |
|